Against Pseudomonas Aeruginosa in Healthy Volunteers.
Phase of Trial: Phase I
Latest Information Update: 02 Nov 2013
At a glance
- Drugs IC 43 (Primary) ; Aluminium hydroxide
- Indications Pseudomonal infections
- Focus Adverse reactions; Pharmacodynamics
- Sponsors Valneva
- 02 Jun 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 05 Jun 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 14 Nov 2008 New trial record.